Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from USANA Health ( (USNA) ).
USANA Health Sciences reported that for the fourth quarter ended Jan. 3, 2026, net sales rose 6% year over year to $226 million, but the company swung to a net loss of $1.8 million, or $0.10 per diluted share, as active customers in its core nutritional segment fell to 387,000 from 454,000. Adjusted diluted EPS slipped 6% to $0.60, while adjusted EBITDA rose 7% to $27 million, with management citing early stabilization in core customer counts and modest sequential sales gains in mainland China, the U.S. and Canada.
For full-year 2025, net sales increased 8% to $925 million, driven mainly by a full-year contribution from Hiya, but net earnings dropped 74% to $10.8 million and adjusted EPS fell 25% as core nutritional sales declined 8% amid tougher customer acquisition. The company highlighted rapid growth at Rise Wellness, with sales tripling off a small 2024 base and non-core brands rising to 16% of total revenue, and guided for flat to mid-single-digit net sales growth and higher earnings in fiscal 2026 as omnichannel brands are expected to exceed 20% of consolidated sales.
The most recent analyst rating on (USNA) stock is a Hold with a $24.00 price target. To see the full list of analyst forecasts on USANA Health stock, see the USNA Stock Forecast page.
Spark’s Take on USNA Stock
According to Spark, TipRanks’ AI Analyst, USNA is a Neutral.
USNA scores moderately, led by a very strong, low-risk balance sheet and solid TTM revenue growth, but weighed down by sharp profitability and cash flow deterioration. Technicals point to a weaker longer-term trend with neutral momentum, while valuation is middling for a business facing margin pressure. Recent commentary and the updated outlook are constructive on venture-brand growth and efficiency actions, but core softness and investment-driven margin tradeoffs keep the score in the mid-range.
To see Spark’s full report on USNA stock, click here.
More about USANA Health
USANA Health Sciences, Inc. is a U.S.-based nutrition and wellness company that sells dietary supplements and related products, with a core nutritional business concentrated in Asia Pacific, the United States and Canada. The company is diversifying through an omnichannel strategy, adding consumer brands such as children’s vitamin brand Hiya and functional snack brand Rise Wellness, and expanding into retail and club channels to reduce reliance on its legacy direct-selling base.
Average Trading Volume: 137,807
Technical Sentiment Signal: Sell
Current Market Cap: $382.1M
For detailed information about USNA stock, go to TipRanks’ Stock Analysis page.